HUT67937A - Method for making prolineboronate esters - Google Patents

Method for making prolineboronate esters

Info

Publication number
HUT67937A
HUT67937A HU9401350A HU9401350A HUT67937A HU T67937 A HUT67937 A HU T67937A HU 9401350 A HU9401350 A HU 9401350A HU 9401350 A HU9401350 A HU 9401350A HU T67937 A HUT67937 A HU T67937A
Authority
HU
Hungary
Prior art keywords
prolineboronate
esters
making
prolineboronate esters
making prolineboronate
Prior art date
Application number
HU9401350A
Other languages
English (en)
Hungarian (hu)
Other versions
HU9401350D0 (en
Inventor
Julian Adams
Roger Snow
Terence A Kelly
Simon Coutts
Clark Perry
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of HU9401350D0 publication Critical patent/HU9401350D0/hu
Publication of HUT67937A publication Critical patent/HUT67937A/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/025—Boronic and borinic acid compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HU9401350A 1991-11-22 1992-11-19 Method for making prolineboronate esters HUT67937A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79614891A 1991-11-22 1991-11-22
US93619892A 1992-08-26 1992-08-26

Publications (2)

Publication Number Publication Date
HU9401350D0 HU9401350D0 (en) 1994-08-29
HUT67937A true HUT67937A (en) 1995-05-29

Family

ID=27121696

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9401350A HUT67937A (en) 1991-11-22 1992-11-19 Method for making prolineboronate esters

Country Status (17)

Country Link
EP (1) EP0641347A1 (fr)
JP (1) JPH07501078A (fr)
CN (1) CN1073946A (fr)
AU (1) AU661362B2 (fr)
CA (1) CA2123128A1 (fr)
CZ (1) CZ124494A3 (fr)
FI (1) FI942345A0 (fr)
HU (1) HUT67937A (fr)
IL (1) IL103817A0 (fr)
MX (1) MX9206628A (fr)
NO (1) NO941905L (fr)
NZ (1) NZ245207A (fr)
PT (1) PT101079A (fr)
SI (1) SI9200332A (fr)
SK (1) SK59294A3 (fr)
TW (1) TW232697B (fr)
WO (1) WO1993010127A1 (fr)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6825169B1 (en) 1991-10-22 2004-11-30 Trustees Of Tufts College Inhibitors of dipeptidyl-aminopeptidase type IV
US5965532A (en) * 1996-06-28 1999-10-12 Trustees Of Tufts College Multivalent compounds for crosslinking receptors and uses thereof
US6040145A (en) 1997-05-07 2000-03-21 Tufts University Potentiation of the immune response
US6100234A (en) 1997-05-07 2000-08-08 Tufts University Treatment of HIV
ATE357509T1 (de) 1997-09-29 2007-04-15 Point Therapeutics Inc Stimulierung von hämatopoietischen zellen im vitro
IL139247A0 (en) 1998-05-04 2001-11-25 Point Therapeutics Inc Hematopoietic stimulation
JP2002517401A (ja) * 1998-06-05 2002-06-18 ポイント セラピューティクス， インコーポレイテッド 環状ボロプロリン化合物
US6979697B1 (en) 1998-08-21 2005-12-27 Point Therapeutics, Inc. Regulation of substrate activity
US6890904B1 (en) 1999-05-25 2005-05-10 Point Therapeutics, Inc. Anti-tumor agents
EP1259246A2 (fr) * 2000-02-25 2002-11-27 Novo Nordisk A/S Inhibition de la degenerescence des cellules beta
WO2003063903A2 (fr) * 2002-02-01 2003-08-07 Probiodrug Ag Modulation des lymphocytes t au moyen d'inhibiteurs de la dp iv
US7317109B2 (en) 2003-11-12 2008-01-08 Phenomix Corporation Pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV
US7767828B2 (en) 2003-11-12 2010-08-03 Phenomix Corporation Methyl and ethyl substituted pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV
SG134333A1 (en) * 2003-11-12 2007-08-29 Phenomix Corp Heterocyclic boronic acid compounds
US7576121B2 (en) 2003-11-12 2009-08-18 Phenomix Corporation Pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV
WO2005049022A2 (fr) 2003-11-17 2005-06-02 Novartis Ag Utilisation de composes organiques
RU2766487C2 (ru) 2004-01-20 2022-03-15 Новартис Аг Композиция и способ прямого прессования
TW200604137A (en) 2004-04-27 2006-02-01 Wyeth Corp Coupling process for generating reactive boron-containing derivatives of n-substituted pyrrole-2-carbonitriles to produce biaryls
DOP2006000008A (es) 2005-01-10 2006-08-31 Arena Pharm Inc Terapia combinada para el tratamiento de la diabetes y afecciones relacionadas y para el tratamiento de afecciones que mejoran mediante un incremento de la concentración sanguínea de glp-1
US7399869B2 (en) 2005-05-19 2008-07-15 Genentech, Inc. Fibroblast activation protein inhibitor compounds and methods
US7825139B2 (en) 2005-05-25 2010-11-02 Forest Laboratories Holdings Limited (BM) Compounds and methods for selective inhibition of dipeptidyl peptidase-IV
CN1331835C (zh) * 2005-10-18 2007-08-15 武汉大学 光活性β－羟基酮的制备方法
JP5270369B2 (ja) * 2005-12-19 2013-08-21 タフツ ユニバーシティー／トラスティーズ オブ タフツ カレッジ ソフトプロテアーゼ抑制剤およびそのプロソフト型
US7833730B2 (en) 2006-04-11 2010-11-16 Arena Pharmaceuticals, Inc. Methods of using GPR119 to identify compounds useful for increasing bone mass in an individual
PE20071221A1 (es) 2006-04-11 2007-12-14 Arena Pharm Inc Agonistas del receptor gpr119 en metodos para aumentar la masa osea y para tratar la osteoporosis y otras afecciones caracterizadas por masa osea baja, y la terapia combinada relacionada a estos agonistas
EP2108960A1 (fr) 2008-04-07 2009-10-14 Arena Pharmaceuticals, Inc. Procédés d'utilisation d'un récepteur couplé à protéine G pour identifier les secrétagogues de peptide YY (PYY) et composés utiles dans le traitement des conditions modulées de secrétagogues BY (PYY) et composés utiles dans le traitement des conditions par PYY
EP2730579A1 (fr) 2008-06-17 2014-05-14 Millennium Pharmaceuticals, Inc. Composés de borates esters et compositions pharmaceutiques contenant des composés
AR077642A1 (es) 2009-07-09 2011-09-14 Arena Pharm Inc Moduladores del metabolismo y el tratamiento de trastornos relacionados con el mismo
CA2795513A1 (fr) 2010-04-06 2011-10-13 Arena Pharmaceuticals, Inc. Modulateurs du recepteur de gpr119 et traitement de troubles associes
EP3323818A1 (fr) 2010-09-22 2018-05-23 Arena Pharmaceuticals, Inc. Modulateurs du récepteur gpr119 et traitement de troubles associés
US20140018371A1 (en) 2011-04-01 2014-01-16 Arena Pharmaceuticals, Inc. Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
WO2012145361A1 (fr) 2011-04-19 2012-10-26 Arena Pharmaceuticals, Inc. Modulateurs du récepteur gpr119 et traitement de troubles liés à celui-ci
US20140051714A1 (en) 2011-04-22 2014-02-20 Arena Pharmaceuticals, Inc. Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
US20140038889A1 (en) 2011-04-22 2014-02-06 Arena Pharmaceuticals, Inc. Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
WO2012170702A1 (fr) 2011-06-08 2012-12-13 Arena Pharmaceuticals, Inc. Modulateurs du récepteur gpr119 et traitement de troubles associés à celui-ci
WO2013055910A1 (fr) 2011-10-12 2013-04-18 Arena Pharmaceuticals, Inc. Modulateurs du récepteur gpr119 et traitement de troubles associés
WO2014074668A1 (fr) 2012-11-08 2014-05-15 Arena Pharmaceuticals, Inc. Modulateurs de gpr119 et traitement de troubles associés à ceux-ci
US9523687B2 (en) 2014-02-28 2016-12-20 Institut Pasteur Levels of CXCL 10/IP-10 forms and soluble CD26/DPPIV activity as early predictive biomarkers for HIV/SIV associated mucosal inflammation and progression towards AIDS
MA39964A (fr) 2014-05-20 2015-11-26 Millennium Pharm Inc Inhibiteurs du protéasome contenant du bore destinés à être utilisés après une thérapie contre le cancer primaire
EA201791982A1 (ru) 2015-03-09 2020-02-17 Интекрин Терапьютикс, Инк. Способы лечения неалкогольной жировой болезни печени и/или липодистрофии
WO2018162722A1 (fr) 2017-03-09 2018-09-13 Deutsches Institut Für Ernährungsforschung Potsdam-Rehbrücke Inhibiteurs de dpp-4 à utiliser dans le traitement de fractures osseuses
JP2020515639A (ja) 2017-04-03 2020-05-28 コヒラス・バイオサイエンシズ・インコーポレイテッド 進行性核上性麻痺の処置のためのＰＰＡＲγアゴニスト
CN108047257B (zh) * 2017-12-17 2020-03-13 沧州普瑞东方科技有限公司 一种手性n-boc-吡咯烷-2-硼酸的制备工艺
CN111741939B (zh) * 2018-02-20 2026-04-17 大塚制药株式会社 制备4-二羟硼基苯丙氨酸的方法
CN110452258B (zh) * 2019-09-03 2021-01-01 上海馨远医药科技有限公司 一种二肽缬氨酸硼脯氨酸盐的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4935493A (en) * 1987-10-06 1990-06-19 E. I. Du Pont De Nemours And Company Protease inhibitors
EP0528858B1 (fr) * 1990-04-14 1997-01-22 New England Medical Center Hospitals, Inc. Inhibiteurs de dipeptidyl-aminopeptidase de type iv
GB9017694D0 (en) * 1990-08-13 1990-09-26 Sandoz Ltd Improvements in or relating to organic chemistry

Also Published As

Publication number Publication date
CN1073946A (zh) 1993-07-07
AU661362B2 (en) 1995-07-20
NO941905L (no) 1994-07-14
FI942345A7 (fi) 1994-05-20
FI942345A0 (fi) 1994-05-20
AU3136893A (en) 1993-06-15
EP0641347A1 (fr) 1995-03-08
SK59294A3 (en) 1995-02-08
CA2123128A1 (fr) 1993-05-27
CZ124494A3 (en) 1995-07-12
MX9206628A (es) 1993-05-01
IL103817A0 (en) 1993-04-04
NO941905D0 (no) 1994-05-20
NZ245207A (en) 1994-07-26
PT101079A (pt) 1994-02-28
WO1993010127A1 (fr) 1993-05-27
JPH07501078A (ja) 1995-02-02
TW232697B (fr) 1994-10-21
HU9401350D0 (en) 1994-08-29
SI9200332A (en) 1993-06-30

Similar Documents

Publication Publication Date Title
HUT67937A (en) Method for making prolineboronate esters
HU9203542D0 (en) Method for producing 1-isoleucine
HU9202830D0 (en) Method for producing 1-treonine
HU912820D0 (en) Method for producing 1-triptophane
HUT64972A (en) Method for producing new steroide esters
HU9302928D0 (en) Process for producing phenol-2-pyperidino-1-alkanyl esters
HU9300999D0 (en) Method for producing imidazo-pyridines
HU9204019D0 (en) Method for producing 2-alkoxi-methyl-acroleine
HU9301807D0 (en) Method for producing dinitro-toluols
GB2259822B (en) D F Method
HU9301934D0 (en) Method for producing heterocyclyl-phenoxy-alkyl-piperidinyl-pyridazines
HU9300927D0 (en) Method for hetero-annulation
EP0520815A3 (en) Method for producing ortho-alkoxybenzoic acid
HU9203897D0 (en) Method for producing 4-amino-5-hexenic acid
GB9111738D0 (en) Method
HU9202622D0 (en) Method for producing succinyl-choline-halides
HU9204042D0 (en) Method for producing alkenoles
GB9224694D0 (en) Object selection method
ZW12792A1 (en) Defaunation method
HU9202987D0 (en) Method for producing peneme esters
EP0494620A3 (en) Process for preparing trans-beta-aroylacrylic ester
HU9301082D0 (en) Method for producing 2-amino-5-methyl-pyridine
HU913015D0 (en) Method for producing v-penicillin-sulphoxide-diphenyl-methyl-ether
HU9203403D0 (en) Method for producing 3-amino-2-phenyl-piperidine
LTIP166A (en) Method for making point

Legal Events

Date Code Title Description
DFD9 Temporary protection cancelled due to non-payment of fee